2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative
Subash S Heraganahally1,2,3,4, Sanjiwika L Wasgewatta1, Kelly McNamara1,2,3
1Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Approximately 32% of Aboriginal Australians with chronic obstructive pulmonary disease (COPD) also have bronchiectasis. These patients experienced lower BMI, more hospital admissions, and reduced lung function compared to those with COPD alone.
Area of Science:
- Pulmonary Medicine
- Indigenous Health
- Respiratory Diseases
Background:
- Chronic respiratory disorders, including COPD and bronchiectasis, are highly prevalent in Aboriginal Australians.
- There is limited data on Aboriginal patients with COPD, particularly those with co-existing bronchiectasis.
Purpose of the Study:
- To evaluate the demographic and clinical characteristics of adult Aboriginal Australian patients diagnosed with COPD, with and without bronchiectasis.
- To investigate differences between COPD patients with and without bronchiectasis in remote Northern Territory communities.
Main Methods:
- Retrospective review of clinical records for demographics, comorbidities, COPD treatment, hospital admissions, and exacerbations.
- Analysis of chest radiology (X-ray, CT scans) to confirm bronchiectasis.
- Inclusion of spirometry, sputum cultures, and cardiac investigations in the data extraction.
Main Results:
- Out of 380 COPD patients, 31.8% (82/258) had co-existent bronchiectasis.
- Patients with COPD and bronchiectasis had a lower BMI (22 vs 24 kg/m²), more frequent hospital admissions (2.0 vs 1.5/year), and a higher prevalence of productive cough.
- Spirometry indicated airflow limitation (FEV1/FVC < 0.7) in most patients, with a marginally lower mean FEV1 (39% vs 43%) in those with bronchiectasis.
Conclusions:
- A significant proportion (32%) of Aboriginal Australians with COPD also present with bronchiectasis.
- Co-existent bronchiectasis in COPD patients is associated with poorer clinical outcomes, including lower BMI, increased hospitalizations, and reduced lung function.
- Further research and targeted interventions are needed for this vulnerable population.
More Related Videos
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
